| Type | Title | Date Released | |
|---|---|---|---|
SCHEDULE 13G | FMR LLC (Filed by) | ||
DEFA14A | Form DEFA14A | ||
DEFA14A | Form DEFA14A | ||
8-K | Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany | ||
SCHEDULE 13G/A | Tetragon Financial Management LP (Filed by) | ||
SCHEDULE 13G | Tetragon Financial Management LP (Filed by) | ||
SCHEDULE 13D/A | Griffiths Richard Ian (Filed by) | ||
SCHEDULE 13G/A | Invus Global Management, LLC (Filed by) | ||
4 | Griffiths Richard Ian (Reporting) | ||
8-K | Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares | ||
424B5 | REGISTERED OFFERING | ||
S-3MEF | August 2026 SHELF |
